Brief: Moberg Pharma Regains Full Rights To Mob-015 In Japan
March 9 (Reuters) - Moberg Pharma AB (publ) MBPH.ST :
* MOBERG PHARMA REGAINS FULL RIGHTS TO MOB-015 IN JAPAN
* REGAINS FULL RIGHTS TO PRODUCT IN JAPAN AND RETAINS
MILESTONE
REVENUES PAID BY TAISHO
Source text for Eikon: ID:nWkr8h9DNQ
Further company coverage: MBPH.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Moberg Pharma AB (publ)
See all newsSweden's Moberg Pharma Q2 loss narrows as revenue rises
Brief: Moberg Pharma Q2 EBITDA SEK -4.3 Million
Brief: Moberg Pharma Names Vaidrius Navikas Chief Medical Officer
Brief: Moberg Pharma And Karo Healthcare Expand Collaboration
Moberg Pharma Q1 revenue rises, losses narrow on Nordic market share gains